Published in Agents Actions on April 01, 1978
Effects of dissolucytotic gold ions on recovering brain lesions. Histochem Cell Biol (2010) 0.83
Action of gold salts in some inflammatory and immunological models. Agents Actions (1980) 0.78
Effect of two gold compounds on lysosomes. Ann Rheum Dis (1988) 0.75
Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet (1989) 9.76
Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature (1996) 6.20
Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev (2001) 4.68
Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum (2009) 3.61
Myocardial sarcoidosis. Br Heart J (1972) 3.27
How best to fix a broken hip. Fractured Neck of Femur Health Outcomes Project Team. Med J Aust (1999) 3.25
Crystal structure of colicin Ia. Nature (1997) 2.57
Spinal-cord injuries in Australian footballers, 1960-1985. Med J Aust (1987) 2.29
Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. J Biol Chem (1997) 2.15
Isolation of Mycobacterium paratuberculosis from the milk of a cow with Johne's disease. Vet Rec (1981) 2.02
PANNOTATOR: an automated tool for annotation of pan-genomes. Genet Mol Res (2013) 1.74
The structure and stability of an HLA-A*0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site. J Immunol (2000) 1.74
Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J (1999) 1.69
Assembly, specific binding, and crystallization of a human TCR-alphabeta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2. J Immunol (1996) 1.59
Structure of the lnlB leucine-rich repeats, a domain that triggers host cell invasion by the bacterial pathogen L. monocytogenes. Mol Cell (1999) 1.59
Aneurysmal bone cysts of the spine. J Bone Joint Surg Br (1978) 1.54
The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int (1987) 1.54
Methylprednisolone in the management of acute spinal cord injuries. Med J Aust (1990) 1.53
Differentiation of the T helper phenotypes by analysis of the methylation state of the IFN-gamma gene. J Immunol (1994) 1.52
Kappa B site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-Rel. Mol Cell Biol (1992) 1.52
Hyaluronan molecular weight and polydispersity in some commercial intra-articular injectable preparations and in synovial fluid. Inflamm Res (2001) 1.49
The c-rel protooncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element. Proc Natl Acad Sci U S A (1992) 1.49
Lactational competence and involution of the mouse mammary gland require plasminogen. Development (2000) 1.48
Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism. BMJ (1989) 1.48
Why mucous plugs commonly cause left lung collapse? Indian J Pediatr (1987) 1.45
A reappraisal of acute traumatic central cord syndrome. J Bone Joint Surg Br (1986) 1.45
Prognostic value of baseline high-sensitivity C-reactive protein in patients undergoing replacement arthroplasty. JNMA J Nepal Med Assoc (2010) 1.45
Changing pattern of peptic ulcer in India. An endoscopic study of 1,188 ulcer patients. J Clin Gastroenterol (1991) 1.43
Plasma lipids following renal transplantation. Transplantation (1973) 1.42
Chemonucleolysis: a further look at a contentious issue. Med J Aust (1990) 1.41
Expression of NFAT-family proteins in normal human T cells. Mol Cell Biol (1997) 1.41
Mechanoreception in Arthropoda: the chain from stimulus to behavioral pattern. Cold Spring Harb Symp Quant Biol (1965) 1.41
Odontoid fractures in the elderly. J Spinal Disord (1993) 1.40
Observation of an antimatter hypernucleus. Science (2010) 1.38
Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response. Cancer Res (1997) 1.36
Intervertebral disc calcification syndromes in children. J Bone Joint Surg Br (1982) 1.36
Feasibility of long-term plasmacholesterol reduction by diet. Lancet (1972) 1.34
Insulin secretion following myocardial infarction with particular respect to the pathogenesis of cardiogenic shock. Lancet (1969) 1.32
RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter. Mol Cell Biol (1995) 1.29
High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer. Clin Cancer Res (2000) 1.27
Nuclear magnetic resonance (NMR) imaging of iron oxide-labeled neural transplants. Exp Neurol (1993) 1.25
Structure of the Rho-activating domain of Escherichia coli cytotoxic necrotizing factor 1. Nat Struct Biol (2001) 1.25
Vestibular recruitment and decruitment. Acta Otolaryngol (1979) 1.25
Analysis of T-cell proliferation and cytokine secretion in the individuals exposed to arsenic. Hum Exp Toxicol (2008) 1.24
Evidence for articular cartilage regeneration in MRL/MpJ mice. Osteoarthritis Cartilage (2008) 1.24
Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. Br J Cancer (1999) 1.24
Characterization of an arginine 789 to cysteine substitution in alpha 1 (II) collagen chains of a patient with spondyloepiphyseal dysplasia. J Biol Chem (1993) 1.23
Offspring of normal and diabetic rats fed saturated fat in pregnancy demonstrate vascular dysfunction. Circulation (1999) 1.21
Morphological studies of the canine intervertebral disc. The assignment of the beagle to the achondroplastic classification. Res Vet Sci (1975) 1.20
Effects of transforming growth factor beta on proteoglycan synthesis by cell and explant cultures derived from the knee joint meniscus. Osteoarthritis Cartilage (1995) 1.19
Topographical analysis of the structural, biochemical and dynamic biomechanical properties of cartilage in an ovine model of osteoarthritis. Osteoarthritis Cartilage (2003) 1.19
Quantitative comparison and evaluation of software packages for assessment of abdominal adipose tissue distribution by magnetic resonance imaging. Int J Obes (Lond) (2007) 1.18
Directed plasminogen activation at the surface of normal and malignant cells. Adv Cancer Res (1991) 1.17
Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor. Proc Natl Acad Sci U S A (1988) 1.17
Induction of matrix metalloproteinase-2 and -3 activity in ovine nucleus pulposus cells grown in three-dimensional agarose gel culture by interleukin-1beta: a potential pathway of disc degeneration. Eur Spine J (2002) 1.17
Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis. Ann Rheum Dis (1999) 1.15
Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun. J Biol Chem (1995) 1.13
Suppression of Helicobacter pylori reduces gastrin releasing peptide stimulated gastrin release in duodenal ulcer patients. Gut (1992) 1.13
Effects of long-term practolol therapy on plasma-lipids after acute myocardial infarction. Lancet (1975) 1.13
The effects of intraarticular hyaluronan on cartilage and subchondral bone changes in an ovine model of early osteoarthritis. J Rheumatol (1994) 1.12
Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12
Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator. Int J Cancer (1981) 1.12
Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11
Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance. Lab Invest (1999) 1.10
Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy. Infect Immun (1998) 1.10
Regulation of gelatinase-A (MMP-2) production by ovine intervertebral disc nucleus pulposus cells grown in alginate bead culture by Transforming Growth Factor-beta(1)and insulin like growth factor-I. Cell Biol Int (2001) 1.09
Association of human fas (CD95) with a ubiquitin-conjugating enzyme (UBC-FAP). J Biol Chem (1996) 1.09
Gastric antral vascular ectasia: maintenance treatment with oestrogen-progesterone. Gut (1992) 1.09
A PCR-based test for the specific identification of Mycoplasma mycoides subspecies mycoides SC. J Vet Diagn Invest (1994) 1.08
Binding of haptoglobin, inter-alpha-trypsin inhibitor, and alpha 1 proteinase inhibitor to synovial fluid hyaluronate and the influence of these proteins on its degradation by oxygen derived free radicals. Ann Rheum Dis (1988) 1.08
Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08
Inflammatory lesions of intervertebral discs in children. J Bone Joint Surg Am (1967) 1.07
Clinical, biochemical and imaging methods of assessing osteoarthritis and clinical trials with agents claiming 'chondromodulating' activity. Osteoarthritis Cartilage (1994) 1.07
Odontoid fractures. A rational approach to treatment. J Bone Joint Surg Br (1982) 1.07
A longitudinal study of the matrix changes induced in the intervertebral disc by surgical damage to the annulus fibrosus. J Orthop Res (1992) 1.07
Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76 TeV. Phys Rev Lett (2011) 1.05
Sequential development of structural and functional alterations in T cells from tumor-bearing mice. J Immunol (1997) 1.05
Statico-dynamic palatopharyngoplasty with transmitted dynamism--a new technique. P N G Med J (1983) 1.05
Biological aspects of bird colouration and avian colour vision including ultraviolet range. Vision Res (1994) 1.05
Structure of the Yersinia type III secretory system chaperone SycE. Nat Struct Biol (2001) 1.05
A framework for interpreting the leucine-rich repeats of the Listeria internalins. Proc Natl Acad Sci U S A (2000) 1.05
Distraction fractures of the lumbar spine. J Bone Joint Surg Br (1982) 1.05
Why have we been more successful in reducing tobacco use than violent crime? Am J Community Psychol (2000) 1.05
Birds, berries and UV. A note on some consequences of UV vision in birds. Naturwissenschaften (1982) 1.04
Inactive proenzyme to tissue-type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody. EMBO J (1984) 1.03
Characterization of a silencer regulatory element in the human interferon-gamma promoter. J Biol Chem (1994) 1.02
Proteoglycan chemistry of the intervertebral disks. Clin Orthop Relat Res (1978) 1.02
Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J Vasc Surg (1996) 1.01
Metabotropic glutamate receptor mGluR5 subcellular distribution and developmental expression in hypothalamus. J Comp Neurol (1995) 1.01
Acute spinal cord compression in Scheuermann's disease. J Bone Joint Surg Br (1982) 1.01
Major vascular injuries in lumbar disc surgery. J Bone Joint Surg Br (1969) 1.00
Molecular basis of a novel oncogenic mutation in GNAO1. Oncogene (2011) 1.00
Hyaluronan-phospholipid interactions. J Struct Biol (1997) 1.00
A method for the quantitation of hyaluronan (hyaluronic acid) in biological fluids using a labeled avidin-biotin technique. Anal Biochem (1990) 1.00